Stock listing
Intercure Ltd.
Selected listing: INCR · TASE · ILA · IL
Intercure Ltd. (TASE:INCR), Health Technology. Latest release Apr 30, 2026: InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive…
- Ticker
- TASE:INCR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- TASE
- Currency
- ILA
About Intercure Ltd.
Intercure Ltd. is a public company listed under the ticker INCR, operating in the Israeli market. Intercure focuses on the cannabis sector, providing a range of products and services.
Latest news from Intercure Ltd.
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
April 30, 2026
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
March 3, 2026
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
February 19, 2026
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
February 19, 2026
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
November 3, 2025